Primary biliary cirrhosis: Report of a focus study group
โ Scribed by Nora V. Bergasa; Andrew Mason; Annarosa Floreani; Jenny Heathcote; Mark G. Swain; David E. J. Jones; Keith M. Lindor; Margaret F. Bassendine; Howard J. Worman
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 981 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
o provide a forum for discussion in specific areas of liver disease, the Clinical Research Committee T of the American Association for the Study of Liver Disease (AASLD) conceived the Focus Study Group. The first Focus Study Group was organized by Nora V. Bergasa and Howard H. Worman. It was dedicated to primary biliary cirrhosis (PBC) and met on October 25th, 2003, during the AASLD annual meeting. The purpose of this symposium was to identify areas of research and to establish national and international collaborations to study PBC and its complications. The program was prepared from topics provided by investigators in the field, in response to questions posed by the organizers, and it was divided in three sections: pathogenesis, the study of fatigue, and treatment of PBC.
An overview on the pathogenesis of PBC was presented by Dr. Eric M. Gershwin (University of California at Davis, CA)' and was followed by the presentations of invited speakers, all ofwhom are investigators in the field. In this report, abstracted presentations provided by the speakers and the salient points that evolved from the discussion sections are provided.
๐ SIMILAR VOLUMES
Background: Fetal cells can be found in the maternal circulation in most pregnancies. Fetal progenitor cells have been found to persist in the circulation of women many years after childbirth. We tested the hypothesis that microchimerism is involved in the pathogenesis of scleroderma. Scleroderma is
To assess the pathogenetic mechanisms involved in the accumulation of copper in primary biliary cirrhosis (PBC), the kinetics of 64Copper ("Cu) were studied in 6 healthy volunteers, 3 patients with PBC (Stages I to 111) and a normal liver copper, and 7 patients with PBC (Stages I1 to IV) and a high